SAB has entered into a definitive merger agreement with Big Cypress Acquisition Corp. (NASDAQ: BCYP) Click to Read More

Click for Webcast Replay
RSS
Human Trials Expected To Start Next Month For Covid-19 Treatment Derived From Cows’ Blood

Human Trials Expected To Start Next Month For Covid-19 Treatment Derived From Cows’ Blood

June 16, 2020
This Cow’s Antibodies Could Be The Newest Weapon Against COVID-19

This Cow’s Antibodies Could Be The Newest Weapon Against COVID-19

June 5, 2020
Researchers Use Cows To Develop Antibody Treatment

Researchers Use Cows To Develop Antibody Treatment

May 20, 2020
I Am BIO | “Herd” Immunity Podcast

I Am BIO | “Herd” Immunity Podcast

May 7, 2020
Convalescent Serum Lines Up As First-Choice Treatment For Coronavirus

Convalescent Serum Lines Up As First-Choice Treatment For Coronavirus

May 1, 2020
Jodi’s Journal: The Little Biotech Company That Could Beat COVID-19

Jodi’s Journal: The Little Biotech Company That Could Beat COVID-19

April 26, 2020
Behind SAB’s Rapid Response To COVID-19

Behind SAB’s Rapid Response To COVID-19

April 24, 2020
HHS Facilitates Development Of Immunotherapies For COVID-19 Patients

HHS Facilitates Development Of Immunotherapies For COVID-19 Patients

April 13, 2020
BARDA, Department Of Defense, And SAb Biotherapeutics To Partner To Develop A Novel COVID-19 Therapeutic

BARDA, Department Of Defense, And SAb Biotherapeutics To Partner To Develop A Novel COVID-19 Therapeutic

April 2, 2020
Sioux Falls Biotech Firm Rushing To Develop Coronavirus Treatment

Sioux Falls Biotech Firm Rushing To Develop Coronavirus Treatment

March 12, 2020
Personal Impact, Global Influence, Right Here In South Dakota

Personal Impact, Global Influence, Right Here In South Dakota

February 18, 2020